Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $70.47 | Prev. Close $70.52 | Circuit Range N/A |
Day Range $70.47 - $70.95 | Year Range $19.45 - $102.81 | Volume 937 |
Average Traded $70.74 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jan-26 | $66.38 | $68.14 | -1.96% |
16-Jan-26 | $71.59 | $69.50 | -2.18% |
15-Jan-26 | $74.46 | $71.05 | -5.57% |
14-Jan-26 | $74.20 | $75.24 | +1.52% |
13-Jan-26 | $72.31 | $74.11 | +1.39% |
12-Jan-26 | $73.33 | $73.10 | -2.25% |
09-Jan-26 | $74.97 | $74.78 | -0.21% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?